Concepedia

Discovery of novel pyrazole derivatives as potential anticancer agents in MCL

Fansheng Ran, Yang Liu, Daoguang Zhang, Meixia Liu, Guisen Zhao

Bioorganic & Medicinal Chemistry Letters · 2019 · 33 citations · 13 references

Open access

Concepts

PharmacyMedicinal ChemistryOncologyCancer PharmacologyChemotherapyDrug DiscoveryAntineoplastic Drug ClassesCytotoxic ChemotherapyLead Compound DesignLigand-based DesignPharmacodynamics Of Anticancer AgentsStructure-activity Relationship AnalysisAnticancer ChemotherapyAnticancer Compound ScreeningMedicinal HeterocyclesPyrazole ChemistryPyrimidine Analogues

References

13

Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001

Lindsay M. Morton, Sophia Wang, Susan S. Devesa et al. · Blood · 2005 · 1.7K citations · Full text

Medicine, Oncology, Cancer Epidemiology +13

Targeting BTK with Ibrutinib in Relapsed or Refractory Mantle-Cell Lymphoma

Michael Wang, Simon Rule, Peter Martin et al. · New England Journal of Medicine · 2013 · 1.7K citations · Full text

Medicine, Hematology, Pharmacology +17

Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia

Satoshi Tsukada, Douglas C. Saffran, David J. Rawlings et al. · Cell · 1993 · 1.3K citations

Life Sciences, Genetics, Molecular Genetics +17

Discovery of Selective Irreversible Inhibitors for Bruton’s Tyrosine Kinase

Zhengying Pan, Heleen Scheerens, Shyr‐Jiann Li et al. · ChemMedChem · 2006 · 675 citations

Medicine, Medicinal Chemistry, Pharmacology +14

Targeting Bruton tyrosine kinase with ibrutinib in relapsed/refractory marginal zone lymphoma

Ariela Noy, Sven de Vos, Catherine Thiéblemont et al. · Blood · 2017 · 293 citations · Full text

Medicine, Oncology, Pharmacology +13